"In fiscal 2024, we reported strong financial and operational progress, including revenues up 6% to 969,000,"commentedPetVivoCEO,JohnLai."Ourrevenuegrowthwasdrivenlargelybyourexpandeddistributornetwork,withsalesofSpryng™bydistributorsup15732,000. This helped drive our gross profit up 6% to $740,000, with our gross margins improving 40 basis points to 76.3%. "Also during the year, we developed clinical data on the safety and efficacy of Spryng, increased distribution through th ...
